This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Codanthrusate

Authoring team

  • danthron is a stimulant laxative
  • it is marketed as co-danthrusate (when combined with docusate) and co-danthramer (when combined with poloxamer '188')
  • danthron is genotoxic and has been shown to be carcinogenic in rodent studies
  • the Committee on Safety on Medicines (CSM) has advised that the use of danthron-containing products be restricted to constipation in the terminally ill patients of all ages

Reference:

  • Current Problems in Pharmacovigilance (2000), 26, 4.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.